Resultados de la búsqueda 261-270 of 16881 for waardenburg syndrome
Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment. Despite not needing therapy, these patients ...
Real-time Disease Monitoring of Metastatic Breast Cancer to Optimize Treatment. Scottsdale/Phoenix, Ariz. The purpose of this study is to identify subtype- ...
The natural course of autosomal dominant polycystic kidney disease (ADPKD) is highly variable and typically characterized by progressive enlargement of cysts ...
Lymphoma is a diversified disease with outcomes differing upon the types and subtypes of lymphoma as well as treatment modalities used. Fertility outcomes in ...
NF2 is a rare condition that causes benign nerve tumors that can affect hearing, balance and other symptoms. Learn about symptoms, diagnosis and current ...
A Study to Evaluate Minimal Residual Disease in Chronic Lymphocytic Leukemia. Rochester, Minn. The purpose of this study is to compare whether minimal residual ...
Jacksonville, Fla. The purpose of this study is to determine if LIF (Leukemia Inhibitory Factor) level is positively correlated with disease progression and ...
The purpose of this study is to determine adverse events and change in disease symptoms of ABBV-383 in adult participants with relapsed/refractory (R/R) MM.
Also, to improve disease control by decreasing the number of spinal relapses ... InPACT-neoadjuvant patients are stratified by disease burden as assessed by ...
Also, to improve disease control by decreasing the number of spinal relapses for patients who achieve a complete response (CR) or partial response (PR) and ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?